Table of Content

Chapter 1. REPORT SUMMARY
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
Chapter 2. MARKET OVERVIEW AND INSIGHTS
2.1. Definition
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendation
2.2.3. Conclusion
2.3. Rules & Regulations
Chapter 3. MARKET DETERMINANT
3.1. Motivators
3.1.1. Increasing Prevalence of Non-Alcoholic Liver Diseases
3.1.2. Increasing Funding for NASH Detection Techniques
3.1.3. Rising Prevalence of Infectious Diseases
3.1.4. Rising Prevalence of Lifestyle Oriented Diseases Such as Type-2 Diabetes
3.2. Restraints
3.2.1. Availability of Substitute Such as Imaging Technology
3.2.2. High Capital Investment
3.3. Opportunities
3.3.1. Rising Number of Clinical Trials
3.3.2. Rising Awareness for Chronic Liver Diseases in Emerging Economies
3.3.3. Shift Towards Non-Invasive Diagnostic Tools for Monitoring of Drugs
Chapter 4. MARKET SEGMENTATION
4.1. Global NASH Biomarkers Market by Biomarker Type
4.1.1. Serum Biomarkers
4.1.2. Hepatic Fibrosis Biomarkers
4.1.3. Apoptosis Biomarkers
4.1.4. Oxidative Stress Biomarkers
4.1.5. Others (Carbon Isotope Markers and miRNA Biomarkers)
4.2. Global NASH Biomarkers Market by End-Users
4.2.1. Hospitals
4.2.2. Diagnostic Laboratories
4.2.3. Academic Research Institute
4.2.4. Pharmaceutical Companies/CRO
Chapter 5. COMPETITIVE LANDSCAPE
5.1. Key Company Analysis
5.2. Key Strategy Analysis
Chapter 6. REGIONAL ANALYSIS
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Roe
6.3. Asia-Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of The World (RoW)
Chapter 7. COMPANY PROFILES
7.1. Allergan PLC
7.2. ALPCO
7.3. Antaros Medical AB
7.4. BioPredictive S.A.S
7.5. Boehringer Ingelheim International GmbH
7.6. Bristol-Myers Squibb Co.
7.7. Covance Inc.
7.8. Enterome SA
7.9. GENFIT SA
7.10. Gilead Sciences, Inc.
7.11. Laboratory Corporation of America Holdings
7.12. NGM Biopharmaceuticals, Inc.
7.13. Nordic Bioscience
7.14. OWL Metabolomics
7.15. Perspectum Diagnostics Ltd
7.16. Prometheus Laboratories Inc.
7.17. ProSciento
7.18. Quest Diagnostics Inc.
7.19. Siemens Healthcare Medical Solutions Ltd.
7.20. Thermo Fisher Scientific, Inc.
7.21. Xeptagen SpA.



List of Figures


FIGURE # 1 GLOBAL NASH BIOMARKERS MARKET SHARE BY TYPE, 2017 VS 2023 (%)
FIGURE # 2 GLOBAL NASH BIOMARKERS MARKET SHARE BY END-USERS, 2017 VS 2023 (%)
FIGURE # 3 GLOBAL NASH BIOMARKERS MARKET SHARE BY GEOGRAPHY, 2017 VS 2023 (%)
FIGURE # 4 US NASH BIOMARKERS MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 5 CANADA NASH BIOMARKERS MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 6 UK NASH BIOMARKERS MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 7 GERMANY NASH BIOMARKERS MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 8 ITALY NASH BIOMARKERS MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 9 SPAIN NASH BIOMARKERS MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 10 FRANCE NASH BIOMARKERS MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 11 ROE NASH BIOMARKERS MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 12 INDIA NASH BIOMARKERS MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 13 CHINA NASH BIOMARKERS MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 14 JAPAN NASH BIOMARKERS MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 15 REST OF ASIA-PACIFIC NASH BIOMARKERS MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE # 16 ROW NASH BIOMARKERS MARKET SIZE, 2017-2023 ($ MILLION)

 

List of Tables


TABLE # 1 GLOBAL NASH BIOMARKERS MARKET RESEARCH AND ANALYSIS BY BIOMARKER TYPE, 2017-2023 ($ MILLION)
TABLE # 2 GLOBAL SERUM BIOMARKERS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 3 GLOBAL HEPATIC FIBROSIS MARKERS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 4 GLOBAL ADOPTOSIS MARKERS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 5 GLOBAL OXIDATIVE STRESS MAKERS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 6 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 7 GLOBAL NASH BIOMARKERS MARKET RESEARCH AND ANALYSIS BY END-USERS, 2017-2023 ($ MILLION)
TABLE # 8 GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 9 GLOBAL DIAGNOSTIC LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 10 GLOBAL ACADEMIC RESEARCH INSTITUTE MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 11 GLOBAL PHARMACEUTICAL COMPANIES/CRO MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
TABLE # 12 GLOBAL NASH BIOMARKERS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023 ($ MILLION)
TABLE # 13 NORTH AMERICA NASH BIOMARKERS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 14 NORTH AMERICA NASH BIOMARKERS MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLION)
TABLE # 15 NORTH AMERICA NASH BIOMARKERS MARKET RESEARCH AND ANALYSIS BY END-USERS, 2017-2023 ($ MILLION)
TABLE # 16 EUROPE NASH BIOMARKERS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 17 EUROPE NASH BIOMARKERS MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLION)
TABLE # 18 EUROPE NASH BIOMARKERS MARKET RESEARCH AND ANALYSIS BY END-USERS, 2017-2023 ($ MILLION)
TABLE # 19 ASIA-PACIFIC NASH BIOMARKERS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE # 20 ASIA-PACIFIC NASH BIOMARKERS MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLION)
TABLE # 21 ASIA-PACIFIC NASH BIOMARKERS MARKET RESEARCH AND ANALYSIS BY END-USERS, 2017-2023 ($ MILLION)
TABLE # 22 ROW NASH BIOMARKERS MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLION)
TABLE # 23 ROW NASH BIOMARKERS MARKET RESEARCH AND ANALYSIS BY END-USERS, 2017-2023 ($ MILLION)